Prostate cancer: genes, environment, immunity and the use of immunotherapy
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Urology,Oncology
Link
http://www.nature.com/articles/pcan20083.pdf
Reference82 articles.
1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ . Cancer statistics, 2007. CA Cancer J Clin 2007; 57: 43–66.
2. McCracken M, Olsen M, Chen Jr MS, Jemal A, Thun M, Cokkinides V et al. Cancer incidence, mortality, and associated risk factors among Asian Americans of Chinese, Filipino, Vietnamese, Korean, and Japanese ethnicities. CA Cancer J Clin 2007; 57: 190–205.
3. Ozanne SE, Constancia M . Mechanisms of disease: the developmental origins of disease and the role of the epigenotype. Nat Clin Pract Endocrinol Metab 2007; 3: 539–546.
4. Travis LB . The epidemiology of second primary cancers. Cancer Epidemiol Biomarkers Prev 2006; 15: 2020–2026.
5. Botti C, Seregni E, Ferrari L, Martinetti A, Bombardieri E . Immunosuppressive factors: role in cancer development and progression. Int J Biol Markers 1998; 13: 51–69.
Cited by 27 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Brain Metastatic Prostate Adenocarcinoma: Avoiding Mistaken Identities;Cureus;2024-09-12
2. The Clinical, Diagnostic, Therapeutic, and Prognostic Characteristics of Brain Metastases in Prostate Cancer: A Systematic Review;Prostate Cancer;2022-11-27
3. The tumor innate immune microenvironment in prostate cancer: an overview of soluble factors and cellular effectors;Exploration of Targeted Anti-tumor Therapy;2022-10-31
4. The Aptamer Functionalized Nanocomposite Used for Prostate Cancer Diagnosis and Therapy;Journal of Nanomaterials;2022-01-11
5. Comparing the frequency of CD33 + pSTAT3 + myeloid‐derived suppressor cells and IL‐17 + lymphocytes in patients with prostate cancer and benign prostatic hyperplasia;Cell Biology International;2021-06-29
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3